Document is current
Any future updates will be listed below
-
Authors
Botty van den Bruele, Astrid https://orcid.org/0000-0002-0621-980X
Weiss, Anna
,
Laronga, Christine
Boughey, Judy C.
Agnese, Doreen
Amin, Miral
Barrio, Andrea V.
Botty van den Bruele, Astrid
Burke, Erin
Dirbas, Frederick
Fayanju, Oluwadamilola
Kantor, Olga
Kumar, Shicha
Nguyen, Toan T.
Park, Ko Un
Plichta, Jennifer
Showalter, Shayna L.
Singh, Puneet
Tranakas, Nicholas
Weiss, Anna
Woodfin, Ashley A.
- License Information
-
More Information
Article History
Received: 20 May 2024
Accepted: 5 June 2024
First Online: 5 July 2024
Disclosure
: Dr. Anna Weiss, MD reports advisory board member/consult payments, Merck, Myriad, Abbvie; Dr. Andrea Barrio reports speaker honorarium, Novartis; Dr. Oluwadamilola Fayanju reports research support outside the current work from Gilead Sciences, Inc. There are no other disclosures to report. The Society of Surgical Oncology Breast Disease Working Group co-sponsored the American Society of Clinical Oncology statement commented upon herein.
Free to read: This content has been made available to all.
